Prostate Cancer - Results from #23820

Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-Year outcomes - Abstract April 17, 2013

Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer - Abstract April 17, 2013

Impact of the radiotherapy technique on the correlation between dose-volume histograms of the bladder wall defined on MRI imaging and dose-volume/surface histograms in prostate cancer patients - Abstract April 17, 2013

Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent - Abstract April 17, 2013

Prostate cancer and androgen deprivation: Benefits of psychological counseling - Abstract April 16, 2013

Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: Results of two prospective trials - Abstract April 16, 2013

A randomized trial comparing seed displacement of coated seeds to regular loose seeds at 30 days postimplant - Abstract April 16, 2013

Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression - Abstract April 16, 2013

Depression and androgen deprivation therapy for prostate cancer: A prospective controlled study - Abstract April 16, 2013

Body mass index and prostate cancer severity: Do obese men harbor more aggressive disease on prostate biopsy? - Abstract April 16, 2013

Rectal and urinary dysfunction in the TROG 03.04 RADAR trial for locally advanced prostate cancer - Abstract April 16, 2013

Intermittent androgen deprivation for aggressive prostate cancer: 8 Years of clinical experience - Abstract April 15, 2013

Intrafraction displacement of prone versus supine prostate positioning monitored by real-time electromagnetic tracking - Abstract April 15, 2013

11C-acetate PET/CT before radical prostatectomy: Nodal staging and treatment failure prediction - Abstract April 15, 2013

Evaluation of adherence to quality measures for prostate cancer radiotherapy in the United States: Results from the Quality Research in Radiation Oncology (QRRO) survey - Abstract April 15, 2013

Initial management of prostate-specific antigen-detected, low-risk prostate cancer and the risk of death from prostate cancer - Abstract April 15, 2013

Ki-67 is an independent predictor of metastasis and cause-specific mortality for prostate cancer patients treated on Radiation Therapy Oncology Group (RTOG) 94-08 - Abstract April 15, 2013

Medium-term outcomes of active surveillance for localised prostate cancer - Abstract April 15, 2013

Clinical controversies: Proton therapy for prostate cancer - Abstract April 15, 2013

Usefulness of prebiopsy multiparametric magnetic resonance imaging and clinical variables to reduce initial prostate biopsy in men with suspected clinically localized prostate cancer - Abstract April 15, 2013

Page 1192 of 1455